Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target (Q45299199)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 November 2005
edit
Language Label Description Also known as
English
Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target
scientific article published on 25 November 2005

    Statements

    Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target (English)
    John S Bett
    Geoffrey M Goellner
    Ben Woodman
    Gregory Pratt
    Martin Rechsteiner
    25 November 2005
    33-44

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit